Director/PDMR Shareholding

RNS Number : 7756P

Judges Scientific PLC

29 October 2012

 



29 October 2012

Judges Scientific plc (the "Company")

Director/PDMR Shareholding

Judges Scientific plc announces transactions by directors and others in the shares of the Company as follows:

Alex Hambro (the Company Chairman) has today given the requisite 30-day notice to convert 200,000 Convertible Redeemable shares, the entirety of his remaining holding of shares of this class, into 25,489 new Ordinary shares of 5p each ("Ordinary Shares").  The amount payable by him to the Company in respect of the conversion is £22,214.  In anticipation of the allotment of these 25,489 new Ordinary shares, he has today sold 15,489 of his existing Ordinary Shares at 860p per share.  Following the completion of these transactions, he will no longer hold any Convertible Redeemable shares and his interests in Ordinary Shares will increase to 110,000 shares representing 2.1% of the issued share capital of that class as increased by all the transactions set out in this announcement.

Ralph Elman (a non-executive Director) has given the requisite 30-day notice to convert 52,083 Convertible Redeemable shares into 6,638 new Ordinary Shares.  The amount payable by him to the Company in respect of the conversion is £5,785.  Following the completion of this transaction, he will retain (through his SIPP) an interest in 208,333 Convertible Redeemable shares, representing the entirety of the shares of this class then outstanding, and his interests in Ordinary Shares will increase to 82,429 shares representing 1.6% of the issued share capital of that class as increased by all the transactions set out in this announcement.

David Barnbrook (Chief Operating Officer) has given the requisite 30-day notice to convert 52,083 Convertible Redeemable shares into 6,638 new Ordinary Shares.  The amount payable by him to the Company in respect of the conversion is £5,785.  In anticipation of the allotment of these 6,638 new Ordinary shares, he has today sold 1,720 of his existing Ordinary Shares at 860p per share.  Following the completion of these transactions, he will no longer hold any Convertible Redeemable shares and his interests in Ordinary Shares will increase to 20,248 shares representing 0.4% of the issued share capital of that class as increased by all the transactions set out in this announcement.  In addition, he holds options over 55,000 Ordinary Shares under the Company's Share Option Plans.

Ralph Cohen (Finance Director) has today exercised options over 8,900 new Ordinary Shares under the Company's Approved Share Option Scheme.  He has also given the requisite 30-day notice to convert 52,083 Convertible Redeemable shares into 6,638 new Ordinary Shares.  The amount payable by him to the Company in respect of the conversion is £5,785.  The new Ordinary Shares arising from this conversion and the above exercise of options will be registered in the name of his wife, Mrs Morwenna Rosemary Cohen.  Following the completion of these transactions, he will no longer hold any Convertible Redeemable shares and his interests in Ordinary Shares will amount to 50,728 shares representing 1.0% of the issued share capital of that class as increased by all the transactions set out in this announcement.  In addition, he holds remaining options over 43,100 Ordinary Shares under the Company's Share Option Plans.

Other staff members have today exercised options over 6,000 new Ordinary Shares under the Company's Approved Share Option Scheme.

Application has been made for the 14,900 new Ordinary Shares issued today to be admitted to AIM and dealings are expected to commence on 5 November 2012; the corresponding application will be made for the shares to be issued at the end of the 30-day notice period on 28 November and dealings are expected to commence on 4 December 2012.  The number of Ordinary Shares currently in issue, including those issued today, is 5,253,096.  Completion of the conversions of Convertible Redeemable shares announced above will further increase the number in issue to 5,298,498.  The number of Convertible Redeemable shares currently in issue is 564,582.  Completion of the conversions announced above will reduce the number outstanding to 208,333.

Alex Hambro, Chairman of Judges Scientific commented: "The accounting treatment of the Convertible Redeemable shares under IFRS has been a cause of confusion and irritation among our shareholders.  I was pleased to announce earlier in the year that a substantial proportion of these shares had been redeemed or converted well in advance of their final conversion date at the end of 2014.  The transactions announced today will reduce the number of these shares still further;  out of the original 5 million shares, only 208,333 will remain outstanding, these being convertible into 0.5% of the enlarged share capital as compared with 12% originally.  Accordingly, the results for 2012 will be the last to reflect any significant distortions relating to the accounting treatment of these shares."

Enquiries:

Judges Scientific plc

David Cicurel, CEO

01342 323 600

Shore Capital

Pascal Keane

Edward Mansfield

020 7408 4090

 

END

 

 

RDSBSBDGGDDBGDC